Erratum: Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice (Human Molecular Genetics (2006) vol. 15 (11) (1884-1893) 10.1093/hmg/ddl111);Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice

Human Molecular Genetics

Volumn 15, Issue 11, 2006, Pages 1884-1893

  Lloyd, David J ^a,b   Bohan, Sandy ^a   Gekakis, Nicholas ^a  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; FURIN; PROINSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOCRINE DISEASE; ENZYME ACTIVATION; ENZYME DEFICIENCY; GLUCOSE INTOLERANCE; HYPERPHAGIA; HYPOTHALAMUS FUNCTION DISORDER; INSULIN RESISTANCE; METABOLISM; MOUSE; MOUSE MUTANT; MUTATIONAL ANALYSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PROCESSING;

EID: 33744763342     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn254     Document Type: Erratum

References (43)

1. Barsh, G.S., Farooqi, I.S. and O'Rahilly, S. (2000) Genetics of body-weight regulation. Nature, 404, 644-651.
2. Beinfeld, M.C. (1998) Prohormone and proneuropeptide processing. Recent progress and future challenges. Endocrine, 8, 1-5.
3. Steiner, D.F. (1998) The proprotein convertases. Curr. Opin. Chem. Biol., 2, 31-39.
4. Jackson, R.S., Creemers, J.W., Ohagi, S., Raffin-Sanson, M.L., Sanders, L., Montague, C.T., Hutton, J.C. and O'Rahilly, S. (1997) Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet., 16, 303-306.
5. Jackson, R.S., Creemers, J.W., Farooqi, I.S., Raffin-Sanson, M.L., Varro, A., Dockray, G.J., Holst, J.J., Brubaker, P.L., Corvol, P., Polonsky, K.S. et al. (2003) Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J. Clin. Invest., 112, 1550-1560.
6. Naggert, J.K., Fricker, L.D., Varlamov, O., Nishina, P.M., Rouille, Y., Steiner, D.F., Carroll, R.J., Paigen, B.J. and Leiter, E.H. (1995) Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat. Genet., 10, 135-142.
7. Cawley, N.X., Zhou, J., Hill, J.M., Abebe, D., Romboz, S., Yanik, T., Rodriguiz, R.M., Wetsel, W.C. and Loh, Y.P. (2004) The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral deficits. Endocrinology, 145, 5807-5819.
8. Cool, D.R., Normant, E., Shen, F., Chen, H.C., Pannell, L., Zhang, Y. and Loh, Y.P. (1997) Carboxypeptidase E is a regulated secretary pathway sorting receptor: Genetic obliteration leads to endocrine disorders in Cpe(fat) mice. Cell, 88, 73-83.
9. Fricker, L.D. (1988) Carboxypeptidase E. Annu. Rev. Physiol., 50, 309-321.
10. Bailyes, E.M., Bennett, D.L. and Hutton, J.C. (1991) Proprotein-processing endopeptidases of the insulin secretary granule. Enzyme, 45, 301-313.
11. Dhanvantari, S., Seidah, N.G. and Brubaker, P.L. (1996) Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol. Endocrinol., 10, 342-355.
12. Zhou, A. and Mains, R.E. (1994) Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. J. Biol. Chem., 269, 17440-17447.
13. Jutras, I., Seidah, N.G., Reudelhuber, T.L. and Brechler, V. (1997) Two activation states of the prohormone convertase PC1 in the secretary pathway. J. Biol. Chem., 272, 15184-15188.
14. Benjannet, S., Rondeau, N., Paquet, L., Boudreault, A., Lazure, C., Chretien, M. and Seidah, N.G. (1993) Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: Glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2. Biochem. J., 294, 735-743.
15. Coates, L.C. and Birch, N.P. (1997) Posttranslational maturation of the prohormone convertase SPC3 in vitro. J. Neurochem., 68, 828-836.
16. Zhou, Y. and Lindberg, I. (1994) Enzymatic properties of carboxyl-terminally truncated prohormone convertase 1 (PC1/SPC3) and evidence for autocatalytic conversion. J. Biol. Chem., 269, 18408-18413.
17. Zhou, Y., Rovere, C., Kitabgi, P. and Lindberg, I. (1995) Mutational analysis of PC1 (SPC3) in PC12 cells. 66-kDa PC1 is fully functional. J. Biol. Chem., 270, 24702-24706.
18. Coates, L.C. and Birch, N.P. (1998) Differential cleavage of provasopressin by the major molecular forms of SPC3. J. Neurochem., 70, 1670-1678.
19. Fricker, L.D., Berman, Y.L., Leiter, E.H. and Devi, L.A. (1996) Carboxypeptidase E activity is deficient in mice with the fat mutation. Effect on peptide processing. J. Biol. Chem., 271, 30619-30624.
20. Berman, Y., Mzhavia, N., Polonskaia, A. and Devi, L.A. (2001) Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice. J. Biol. Chem., 276, 1466-1473.
21. Zhu, X., Zhou, A., Dey, A., Norrbom, C., Carroll, R., Zhang, C., Laurent, V., Lindberg, I., Ugleholdt, R., Holst, J.J. et al. (2002) Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc. Natl Acad. Sci. USA, 99, 10293-10298.
22. Zhu, X., Orci, L., Carroll, R, Norrbom, C., Ravazzola, M. and Steiner, D.F. (2002) Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc. Natl Acad. Sci. USA, 99, 10299-10304.
23. O'Rahilly, S., Gray, H., Humphreys, P.J., Krook, A., Polonsky, K.S., White, A., Gibson, S., Taylor, K. and Carr, C. (1995) Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N. Engl. J. Med., 333, 1386-1390.
24. Hill, R.M., Ledgerwood, E.C., Brennan, S.O., Pu, L.P., Loh, Y.P., Christie, D.L. and Birch, N.P. (1995) Comparison of the molecular forms of the Kex2/subtilisin-like serine proteases SPC2, SPC3, and furin in neuroendocrine secretory vesicles reveals differences in carboxyl-terminus truncation and membrane association. J. Neurochem., 65, 2318-2326.
25. Pritchard, L.E., Turnbull, A.V. and White, A. (2002) Pro-opiomelanocortin processing in the hypothalamus: Impact on melanocortin signalling and obesity. J. Endocrinol., 172, 411-421.
26. Zhou, A., Bloomquist, B.T. and Mains, R.E. (1993) The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J. Biol. Chem., 268, 1763-1769.
27. Ellacott, K.L. and Cone, R.D. (2004) The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog. Horm. Res., 59, 395-408.
28. Yaswen, L., Diehl, N., Brennan, M.B. and Hochgeschwender, U. (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med., 5, 1066-1070.
29. Bates, S.H., Stearns, W.H., Dundon, T.A., Schubert, M., Tso, A.W., Wang, Y., Banks, A.S., Lavery, H.J., Haq, A.K., Maratos-Flier, E. et al. (2003) STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature, 421, 856-859.
30. Balthasar, N., Dalgaard, L.T., Lee, C.E., Yu, J., Funahashi, H., Williams, T., Ferreira, M., Tang, V., McGovern, R.A., Kenny, C.D. et al. (2005) Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell, 123, 493-505.
31. Huszar, D., Lynch, C.A., Fairchild-Huntress, V., Dunmore, J.H., Fang, Q., Berkemeier, L.R., Gu, W., Kesterson, R.A., Boston, B.A., Cone, R.D. et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell, 88, 131-141.
32. Butler, A.A., Kesterson, R.A., Khong, K., Cullen, M.J., Pelleymounter, M.A., Dekoning, J., Baetscher, M. and Cone, R.D. (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology, 141, 3518-3521.
33. Chen, A.S., Marsh, D.J., Trumbauer, M.E., Frazier, E.G., Guan, X.M., Yu, H., Rosenblum, C.I., Vongs, A., Feng, Y., Cao, L. et al. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet., 26, 97-102.
34. Good, D.J., Porter, F.D., Mahon, K.A., Parlow, A.F., Westphal, H. and Kirsch, I.R. (1997) Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat. Genet., 15, 397-401.
35. Jing, E., Nillni, E.A., Sanchez, V.C., Stuart, R.C. and Good, D.J. (2004) Deletion of the Nhlh2 transcription factor decreases the levels of the anorexigenic peptides alpha melanocyte-stimulating hormone and thyrotropin-releasing hormone and implicates prohormone convertases I and II in obesity. Endocrinology, 145, 1503-1513.
36. Leiter, E.H., Chapman, H.D. and Falany, C.N. (1991) Synergism of obesity genes with hepatic steroid sulfotransferases to mediate diabetes in mice. Diabetes, 40, 1360-1363.
37. Coleman, D.L. and Eicher, E.M. (1990) Fat (fat) and tubby (tub): Two autosomal recessive mutations causing obesity syndromes in the mouse. J. Hered., 81, 424-427.
38. Michaud, E.J., Bultman, S.J., Klebig, M.L., van Vugt, M.J., Stubbs, L.J., Russell, L.B. and Woychik, R.P. (1994) A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. Proc. Natl Acad. Sci. USA, 91, 2562-2566.
39. Lee, Y.S., Poh, L.K. and Loke, K.Y. (2002) A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J. Clin. Endocrinol. Metab., 87, 1423-1426.
40. Lloyd, D.J., Hall, F.W., Tarantino, L.M. and Gekakis, N. (2005) Diabetes insipidus in mice with a mutation in aquaporin-2. PLoS Genet., 1, e20.
41. Wen, B.G., Pletcher, M.T., Warashina, M., Choe, S.H., Ziaee, N., Wiltshire, T., Sauer, K. and Cooke, M.P. (2004) Inositol (1,4,5) trisphosphate 3 kinase B controls positive selection of T cells and modulates Erk activity. Proc. Natl Acad. Sci. USA, 101, 5604-5609.
42. Salvalaggio, P.R., Deng, S., Ariyan, C.E., Millet, I., Zawalich, W.S., Basadonna, G.P. and Rothstein, D.M. (2002) Islet filtration: A simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation, 74, 877-879.
43. Licklider, L.J., Thoreen, C.C., Peng, J. and Gygi, S.P. (2002) Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column. Anal. Chem., 74, 3076-3083.